RSS-Feed abonnieren
DOI: 10.1055/s-0029-1225285
© Georg Thieme Verlag KG Stuttgart · New York
Gastroenterologie 2009
Gastroenterology 2009Publikationsverlauf
Publikationsdatum:
10. Juni 2009 (online)

Was ist neu?
-
Endoskopie: Neue Verfahren zur Dünndarmenteroskopie und Radiofrequenzablation bei Barrett-Ösophagus.
-
Ösophaguserkrankungen: Prävalenz der eosinophile Ösophagitis steigt.
-
Reizdarmsyndrom: Neue Therapieansätze
-
Chronisch entzündliche Darmerkrankungen: Langzeittherapie und postoperative Rezidivprophylaxe mit Azathioprin, Karzinomrisiko bei Morbus Crohn.
-
Gastrointestinale Onkologie: Therapie des Pankreaskarzinoms bleibt Herausforderung; Rauchen als Risikofaktor für viele gastrointestinale Karzinome, Kolonandemone und Pankreatitis.
Literatur
- 1
Akerman P A, Cantero D, Avila J. et al .
The spiral enteroscopy experience
in 101 consecutive patients: safty and efficacy using the Discovery SB.
Gastrointest Endosc.
2008;
67
AB92-93
Reference Ris Wihthout Link
- 2
Bechtler M, Eickhoff A, Riemann J F.
Intervallkarzinom und mögliche Ursachen.
Dtsch
Med Wochenschr.
2008;
133
2458-2462
Reference Ris Wihthout Link
- 3
Baxter N N, Goldwasser M A, Paszat L F. et al .
Association of Colonoscopy
and Death From Colorectal Cancer: A Population-Based, Case–Control
Study.
Ann Intern Med.
2009;
150
1-8
Reference Ris Wihthout Link
- 4
Bokemeyer C, Bondarenko I, Makhson A. et al .
Fluorouracil, leucovorin, and oxaliplatin
with and without cetuximab in the first-line treatment of metastatic
colorectal cancer.
J Clin Oncol.
2009;
10,27
663-671
Reference Ris Wihthout Link
- 5
Botteri E, Iodice S, Bagnardi V. et al .
Smoking and colorectal cancer: a meta-analysis.
JAMA.
2008;
300
2765-2778
Reference Ris Wihthout Link
- 6
Botteri E, Iodice S, Raimondi S. et al .
Cigarette smoking and adenomatous polyps:
a meta-analysis.
Gastroenterology.
2008;
134
388-395
Reference Ris Wihthout Link
- 7
Buscaglia J M, Dunbar K B, Okolo P I. et al .
The spiral enteroscopy training
initiative: results of a prospective study evaluating the Discovery
SB overtube device during small bowel enteroscopy.
Endoscopy.
2009;
41
194-199
Reference Ris Wihthout Link
- 8
D’Haens G R, Vermeire S, van Assche G. et al .
Therapy of metronidazole
with azathioprine to prevent postoperative recurrence of Crohn’s
disease: a controlled randomized trial.
Gastroenterology.
2008;
135
1123-1129
Reference Ris Wihthout Link
- 9
Di Nicolantonio F, Martini M, Molinari F. et al .
Wild-type BRAF is required for response
to panitumumab or cetuximab in metastatic colorectal cancer.
J
Clin Oncol.
2008;
26
5705-5012
Reference Ris Wihthout Link
- 10
Domenech E, Manosa M, Bernal I. et al .
Impact of azathioprine on the prevention
of postoperative Crohn’s disease recurrence: Results of
a prospective, observational, long-term follow-up study.
Inflamm
Bowel Dis.
2008;
14
508-513
Reference Ris Wihthout Link
- 11
Fleischer D E, Overholt B F, Sharma V K. et al .
Endoscopic ablation of Barrett’s
esophagus: a multicenter study with 2,5-year follow-up.
Gastrointest
Endosc.
2008;
68
867-876
Reference Ris Wihthout Link
- 12
Friedman S, Rubin P H, Bodian C. et al .
Screening and surveillance colonoscopy
in chronic Crohn’s colitis: Results of a surveillance program
spanning 25 years.
Clin Gastroenterol Hepatol.
2008;
6
993-998
Reference Ris Wihthout Link
- 13
Gupte A R, Draganov P V.
Eosinophilic
esophagitis.
World J Gastroenterol.
2009;
15
17-24
Reference Ris Wihthout Link
- 14
Hartmann D, Eickhoff A, Tamm B. et al .
Balloon-assisted enteroscopy using a single-balloon technique.
Endoscopy.
2007;
39
E276
Reference Ris Wihthout Link
- 15
Heresbach D, Barrioz T, Lapalus M G. et al .
Miss rate for colorectal neoplastic polyps:
a prospective multicenter study of back-to-back video colonoscopies.
Endoscopy.
2008;
40
284-290
Reference Ris Wihthout Link
- 16
Imperiale T F, Glowinski E A, Lin-Cooper C. et al .
Five-year risk of colorectal
neoplasia after negative screening colonoscopy.
N Engl
J Med.
2008;
359
1218-1224
Reference Ris Wihthout Link
- 17
Iodice S, Gandini S, Maisonneuve P. et al .
Tobacco and the risk of pancreatic cancer:
A review and metaanalysis.
Langenbecks Arch Surg.
2008;
393
535-545
Reference Ris Wihthout Link
- 18
Johanson J F, Drossman D A, Panas R. et al .
Phase II study of lubiprostone for irritable
bowel syndrome with constipation.
Aliement Pharmacol Ther.
2008;
27
685-696
Reference Ris Wihthout Link
- 19
Kapel R C, Miller J K, Torres C. et al .
Eosinophilic esophagitis: Aprevalent disease
in the United States that affects all age groups.
Gastroenterology.
2008;
134
1316-1321
Reference Ris Wihthout Link
- 20
Kindler H L, Gangadhar T, Karrison T. et al .
Final analysis of a randomized phase II
study of bevacizumab (b) and gemcitabine (G) plus cetuximab (C)
or erlotinib (E) in patients with advanced pancreatic cancer.
J Clin Oncol.
2008;
26
4502
Reference Ris Wihthout Link
- 21
Kullmann F, Hollerbach S, Dollinger M M. et al .
Cetuximab plus gemcitabin/oxaliplatin
(GEMOXCET) in first line metastatic pancreatic cancer: a multicenter
phase II study.
Br J Cancer.
2009;
100
1032-1036
Reference Ris Wihthout Link
- 22
Liang P S, Chen T Y, Giovannucci E.
Cigarette smoking and colorectal cancer incidence and mortality:
systematic review and meta-analysis.
Int J Cancer.
2009;
124
2406-2415
Reference Ris Wihthout Link
- 23
Lindkvist B, Appelros S, Manjer J. et al .
A prospective cohort study of smoking in
acute pancreatitis.
Pancreatology.
2008;
8
63-70
Reference Ris Wihthout Link
- 24
Martínez M E, Baron J A, Lieberman D A. et al .
A Pooled Analysis
of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy.
Gastroenterology.
2009;
136
832-841
Reference Ris Wihthout Link
- 25
Neuhaus P, Riess H, Post S. et
al .
CONKO-001: Final results of the randomized, prospective, multicenter
phase III trial of adjuvant chemotherapy with gemcitabine versus
observation in patients with resected pancreatic cancer (PC).
J Clin Oncol.
2008;
26
214s; abstr LBA4504
Reference Ris Wihthout Link
- 26
Picozzi V J, Abrams R A, Traverso L W. et al .
ACOSOG Z05031: Report on
a multicenter, phase II trial for adjuvant therapy of resected pancreatic cancer
using cisplatin, 5-FU, and alpha-interferon.
J Clin Oncol.
2008;
26
4505
Reference Ris Wihthout Link
- 27
Pouw R E, Sharma V K, Bergman J J. et al .
Radiofrequency ablation
for total Barrett’s eradication: a description of the endoscopic
technique, its clinical results and future prospects.
Endoscopy.
2008;
40
1033-1040
Reference Ris Wihthout Link
- 28
Sargent D J, Marsoni S, Thibodeau S N. et al .
Confirmation of deficient mismatch repair
(dMMR) as a predictive marker for lack of benefit from 5-FU based
chemotherapy in stage II and III colon cancer (CC): A pooled molecular
reanalysis of randomized chemotherapy trials.
J Clin Oncol.
2008;
26
180s; abstr 4008
Reference Ris Wihthout Link
- 29
Schorr F, Riemann J F.
Gastroenterologie
2008.
Dtsch Med Wochenschr.
2008;
133
1362-1365
Reference Ris Wihthout Link
- 30
Tol J, Koopman M, Cats A. et
al .
Chemotherapy, bevacizumab, and cetuximab in metastatic
colorectal cancer.
N Engl J Med.
2009;
360
563-572
Reference Ris Wihthout Link
- 31
Treton X, Bouhnik Y, Mary J Y. et al .
Azathioprine withdrawal in patients with
Crohn’s disease maintained on prolonged remission: a high
risk of relapse.
Clin Gastroenterol Hepatol.
2009;
7
80-85
Reference Ris Wihthout Link
- 32
Tsujikawa T, Saiton Y, Andoh A. et al .
Novel single-ballon enteroscopy for diagnosis
and treatment of the small intestine: preliminary experiences.
Endoscopy.
2008;
40
11-15
Reference Ris Wihthout Link
- 33
Van Cutsem E, Lang I, D’Haens G. et al .
KRAS status and efficacy in the first-line
treatment of patients with metastatic colorectal cancer (mCRC) treated
with FOLFIRI with or without cetuximab: The CRYSTAL experience.
J Clin Oncol.
2008;
26
5s; abstr.
Reference Ris Wihthout Link
- 34
Wilhelm S M, Brubaker C M, Varcak E A. et al .
Effectiveness of probiotics
in the treatment of irritable bowel syndrome.
Pharmacotherapy.
2008;
28
496-505
Reference Ris Wihthout Link
- 35 Zijdenbos I L, de Wit N J, van
der Heijden G J. et al .Cochrane
Database Syst Rev 2009 CD006442
Reference Ris Wihthout Link
Dr. med. Friedrich Schorr
Medizinische Klinik C, Klinikum Ludwigshafen
Bremserstrasse 79
67063 Ludwigshafen am Rhein
Telefon: 0621/5034104
Fax: 0621/5034114
eMail: schorrf@klilu.de